Clinical Trials Logo

Clinical Trial Details — Status: Not yet recruiting

Administrative data

NCT number NCT04791189
Other study ID # RNI 2020 SAVEL
Secondary ID
Status Not yet recruiting
Phase
First received
Last updated
Start date May 2021
Est. completion date June 2022

Study information

Verified date March 2021
Source University Hospital, Clermont-Ferrand
Contact Lise LACLAUTRE
Phone +334 73 754 963
Email promo_interne_drci@chu-clermontferrand.fr
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

Sexual health is a legitimate area to explore in the care of these patients, as it has such an impact on quality of life. However, addressing sexual health in a situation of chronic disease confronts the double societal taboo of disease and sexuality. Health professionals are uncomfortable because they are not trained to talk about the subject, especially in the presence of parents and with a teenager they have watched grow up. In this context, a needs survey among juvenile idiopathic arthritis (JIA) patients and the point of view of their parents in the field of sexual health seems necessary. Main objective: To determine the expectations of adolescents (aged 10-19 years) with juvenile idiopathic arthritis regarding knowledge and communication with health care professionals in the field of sexual health.


Description:

This study is non-interventional, multi-centre and does not change current practice. It will begin with the construction in a multidisciplinary team of two "needs assessment" questionnaires, the first for adult patients who have suffered from JIA, the second for their parents. They will be drawn up by three sexologists, two rheumatologists, a pediatrician, a nurse from UTEP, a biostatistician, a statistician specializing in questionnaire metrology, two patients with JIA, two parents of JIA patients, and the Director of the ANDAR patient association. These "needs assessment" questionnaires, entirely anonymous, will be composed of closed, Likert scale or semi-open questions. The questionnaires will be implemented under RedCap° for patient associations. The material necessary for the study (invitation letter + "patients"/"parents"-information letters + paper questionnaires for both surveys + pre-stamped letters) will be in paper format for hospital centres. These centres will ensure the follow-up of the study. The invitation to participate in the survey by mailing or newsletter or association website will be made by the heads of patient associations.


Recruitment information / eligibility

Status Not yet recruiting
Enrollment 300
Est. completion date June 2022
Est. primary completion date February 2022
Accepts healthy volunteers No
Gender All
Age group 18 Years to 45 Years
Eligibility Inclusion Criteria: Patients : - Patients with juvenile rheumatoid arthritis aged from 18 to 45 years - - Major male or female patient [18 to 45 years of age] with juvenile idiopathic arthritis reported before the age of 16. - - Able to understand and complete the questionnaire online (speaking and reading French, with an internet connection for completion via RedCap°). ¬ - - Able to give informed consent to participate - - Involving one's parents in the survey is not a prerequisite for inclusion. Parents : - Parents of patients with juvenile rheumatoid arthritis aged from 18 to 45 years - - Parents of adult patients with JIA - - Parents able to understand and complete the questionnaire online (speaking and reading French, having an internet connection for completion via Red Cap°). - - Able to give informed consent to participate - - The parents must have been in charge of the patient as a teenager. Exclusion Criteria: - Persons opposing participation in the study. The study information letters will specify that participation is consent to participate in the study. - Protected persons

Study Design


Intervention

Other:
questionnaire
questionnaire to survey the needs of adolescents with juvenile idiopathic arthritis and the views of their parents in the area of sexual health.

Locations

Country Name City State
France CHU Bordeaux Pellegrin Bordeau
France AP-HP Boulogne-Billancourt
France Hôpital de La Cavale Blanche Brest
France CHU de Clermont-Ferrand Clermont-Ferrand
France CHUGA - Hôpital Sud Échirolles
France CHR Metz-Thionville Metz
France Association Nationale de Défense contre l'Arthrite Rhumatoïde Montpellier
France CHU de Montpellier Montpellier
France Centre Hospitalier Universitaire de Nantes Nantes
France CHU de Nice Hopital Pasteur Nice
France APHP La Pitié Salpétrière Paris
France Association KOURIR Paris
France CHU de Strasbourg - Hôpital de Hautepierre Strasbourg
France CHU Toulouse Toulouse
France Association France Spondyloarthrite Tulle

Sponsors (2)

Lead Sponsor Collaborator
University Hospital, Clermont-Ferrand Societe Francaise de Rhumatologie

Country where clinical trial is conducted

France, 

Outcome

Type Measure Description Time frame Safety issue
Primary Responses of JIA patients to a questionnaire on their expectations during adolescence regarding knowledge and communication with health professionals in the field of sexual health ("patient needs assessment" questionnaire) . Responses of JIA patients to a questionnaire on their expectations during adolescence regarding knowledge and communication with health professionals in the field of sexual health ("patient needs assessment" questionnaire) Day 1
Secondary Responses of JIA patients to a questionnaire on their expectations during adolescence regarding knowledge and communication with health professionals in the field of sexual health ("patient needs assessment" questionnaire) Responses of JIA patients to a questionnaire on their expectations during adolescence regarding knowledge and communication with health professionals in the field of sexual health ("patient needs assessment" questionnaire) . Day 1
Secondary Responses of parents of JIA patients to a questionnaire on their child's assumed expectations during adolescence regarding knowledge and communication with health professionals in the field of sexual health ("parent needs assessment" questionnaire). Responses of parents of JIA patients to a questionnaire on their child's assumed expectations during adolescence regarding knowledge and communication with health professionals in the field of sexual health ("parent needs assessment" questionnaire). Day 1
See also
  Status Clinical Trial Phase
Completed NCT02776735 - An Open-label, Ascending, Repeated Dose-finding Study of Sarilumab in Children and Adolescents With Polyarticular-course Juvenile Idiopathic Arthritis (pcJIA) Phase 2
Active, not recruiting NCT03092427 - Probiotic Treatment in Juvenile Idiopathic Arthritis (JIA) N/A
Not yet recruiting NCT05545098 - MSUS Versus Serum Survivin and Lubricin Levels in Evaluation of Disease Activity in JIA
Not yet recruiting NCT03833609 - Yoga and Aerobic Dance for Pain Management in Juvenile Idiopathic Arthritis N/A
Completed NCT02524340 - Patient Centered Adaptive Treatment Strategies Using Bayesian Causal Inference
Recruiting NCT01434082 - Sleep Patterns in Children With and Without Juvenile Idiopathic Arthritis N/A
Completed NCT04671524 - The Effect of Improvement in Function on Foot Pressure, Balance and Gait in Children With Upper Extremity Affected N/A
Recruiting NCT04167488 - Assessment of Physical Activity Among Juvenile Idiopathic Arthritis Children Performed With Actigraphy N/A
Recruiting NCT04205500 - Treatment With Specific Carbohydrate Diet in Children With Juvenile Idiopathic Arthritis N/A
Terminated NCT01694264 - Study of Anti-Viral Prophylaxis for HBsAg(+) or HBcAb(+)/HBsAb(-) Patients Starting Anti-TNFα Phase 3
Completed NCT02824978 - Therapeutic Alliance is it Associated With Better Compliance Amongst Children With Juvenile Idiopathic Arthritis ?
Active, not recruiting NCT03841357 - Preventing Extension of Oligoarticular Juvenile Idiopathic Arthritis JIA (Limit-JIA) Phase 3
Completed NCT03833271 - The Efficacy of Influenza Vaccine Program in Children With Juvenile Idiopathic Arthritis. A Single Centre Results From Hungary Early Phase 1
Completed NCT01455701 - A Study to Evaluate Pharmacokinetics and Safety of Tocilizumab (RoActemra/Actemra) in Participants Less Than 2 Years Old With Active Systemic Juvenile Idiopathic Arthritis (sJIA) Phase 1
Completed NCT05031104 - Low-energy Laser Applications in Patients With Juvenile Idiopathic Arthritis N/A
Not yet recruiting NCT01436019 - Study of Antibodies to Anti-TNF Agents in Juvenile Idiopathic Arthritis N/A
Recruiting NCT05609630 - Study of Oral Upadacitinib and Subcutaneous/Intravenous Tocilizumab to Evaluate Change in Disease Activity, Adverse Events and How Drug Moves Through the Body of Pediatric and Adolescent Participants With Active Systemic Juvenile Idiopathic Arthritis. Phase 3
Recruiting NCT05696340 - Access to Pediatric Rheumatology Centers for JIA Patients: Factors Associated With Time to Access Pediatric Rheumatology Centers
Recruiting NCT05545839 - Transition to Adulthood Through Coaching and Empowerment in Rheumatology N/A
Completed NCT05436301 - Turkish Validity and Reliability of Pain Catastrophizing Scale-Child (PCS-C)